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Abstract
Background: Prevention of mother to child transmission of HIV remains a key public health priority in most
developing countries. The provider Initiated Opt – Out Prenatal HIV Screening Approach, recommended by the
World Health Organization (WHO) lately has been adopted and translated into policy in most Sub – Saharan African
countries. To better ascertain the ethical reasons for or against the use of this approach, we carried out a literature
review of the ethics literature.
Methods: Papers published in English and French Languages between 1990 and 2015 from the following data
bases were searched: Pubmed, Cochrane literature, Embase, Cinhal, Web of Science and Google Scholar. After
screening from 302 identified relevant articles, 21 articles were retained for the critical review.
Discussion: Most authors considered this approach ethically justifiable due to its potential benefits to the mother,
foetus and society (Beneficence). The breaching of respect for autonomy was considered acceptable on the
grounds of libertarian paternalism. Most authors considered the Opt - Out approach to be less stigmatizing than
the Opt - In. The main arguments against the Opt - Out approach were: non respect of patient autonomy,
informed consent becoming a meaningless concept and the HIV test becoming compulsory, risk of losing trust in
health care providers, neglect of social and psychological implications of doing an HIV test, risk of aggravation of
stigma if all tested patients are not properly cared for and neglect of sociocultural peculiarities.
Conclusions: The Opt – Out approach could be counterproductive in case gender sensitive issues within the
various sociocultural representations are neglected, and actions to offer holistic care to all women who shall
potentially test positive for HIV were not effectively ascertained. The Provider Initiated Opt – Out Prenatal HIV
Screening option remains ethically acceptable, but deserves caution, active monitoring and evaluation within the
translation of this approach into to practice.
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Acceptability and pregnancy
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Background
Significant progress has been made in curbing HIV –
AIDS prevalence, incidence and burden in the past two
decades. However, over 36 million people still live with
the disease worldwide especially in Sub – Saharan Africa
[1]. The advent of Highly Active Anti-Retroviral Therapy,
(HAART), has drastically changed the course of HIV in-
fected persons. The disease has evolved from being a
deadly infectious condition, to a chronic disease. Nowadays,
most infected persons live a normal life due to the
improved access, availability and effectiveness of Anti –
Retroviral Therapy [1, 2]. Testing pregnant women for HIV
at the time of labour and delivery is the last oppor-
tunity for Prevention of Mother-To-Child HIV trans-
mission (PMTCT) measures, particularly in settings
where women do not receive adequate antenatal care.
About 60 % of the general population globally remains
untested, or is unaware of their HIV status [3]. Despite the
availability and effectiveness of new rapid HIV tests and
prevention strategies, many women are still seen in labor
rooms with uncertain HIV serology status [2, 4]. Tudor
Car and colleagues reported in a recent systematic review
that over 70 % of women admitted to the labor rooms did
not know their HIV status [5].
More than 90 % of the new infections occur during
the prenatal period [1]. Over 75 % of perinatal HIV
transmission occurs during labor and delivery [6]. If the
HIV status of the mother is known especially during the
prenatal or intrapartum period, affordable and effective
interventions (specific medical staff practices and anti –
retroviral therapy) for immediate protection of the neonate
and treatment for the mother can be readily provided.
Transmission rates from infected mothers to their children
could be reduced to 2 % or less with the current Preven-
tion of Mother to Child Transmission of HIV prevention
package [4, 6]. Prenatal and labor room HIV screening
could be a starting point to get to the sexual partners of in-
fected mothers since some of these mothers and their hus-
bands or sexual partners are generally unaware of their
HIV status [2, 5]. The World Health Organization (WHO)
in 2003 reported that only half of the pregnant women liv-
ing with HIV had received Anti Retroviral Therapy for the
prevention of Mother – To – Child Transmission of the
disease [7]. One third (32 %) of women who give birth in
developing countries do so without any previous antenatal
follow up [4, 8]. Worldwide, the main approaches that have
been used in the prenatal HIV testing services are the Opt
– In and Opt – Out approaches.
In the Opt – In approach, the pregnant women are
given pre-HIV test counselling, and they actively choose
to receive the test usually in writing (written informed
consent). With the Opt – Out approach, pregnant
women are informed that an HIV test will be included
in the standard group of prenatal tests (that is to say,
tests given to all pregnant women), and that they may
decline the test. A written document is often not
required and the HIV test is incorporated into the usual
package of routine care tests. Unless they decline, they
will receive an HIV test [9, 10]. However, some authors
have questioned recently if the opt -out approach is
actually justified from an ethical perspective [11–15].
In most Sub – Saharan African countries today, the main
approach to HIV screening in prenatal care settings is
Provider Initiated Testing and Counselling (PITC) using an
Opt - Out approach. Some authors have argued that
women from this region of the world undertake the
HIV test under some degree of implicit or “involuntary”
coercion, and that the consequences when these
women would realize that they actually had a choice
either to turn down or to comply with the test could be
counterproductive [15–19]. These consequences could
range from lack of trust in the health care providers to
refusal to take part in future research activities [20],
[19]. To better appreciate whether this prenatal HIV
screening approach is appropriate or not from an
ethical perspective, we therefore carried out a review of
the literature using a reasons based approach [21, 22].
The main objective of this study was to ascertain the
ethical arguments for or against the provider initiated
opt – out approach in prenatal HIV screening within
the Sub – Saharan African context.
Methods
Multiple and at times potentially conflicting interests are
at stake when it comes to testing the pregnant woman
for HIV: the interests of the pregnant woman, the fetus
and the interest of society [7, 9, 23]. The goal of this
review was to identify the main ethical arguments that
have been put forward in the literature in support of or
against the provider initiated opt – out prenatal HIV
screening approach within the Sub – Saharan African
context. Strech and Sofaer have argued that argument
– based literature reviews are valuable tools that can
be used to improve ethically relevant decisions in
healthcare, research or policy [21]. McCullough et al.
[22] support the use of argument – based literature in
bioethics and propose a four step methodological
framework in performing such a task. The four step
methodological framework proposed by McCullough et al.
in conducting reviews of argument - based literature was
used as the main construct in answering our main research
question of whether the current provider initiated opt –
out prenatal HIV screening approach in Sub – Saharan
Africa is ethically justified or not. These steps were:
I. Identifying a focused question: Is the Opt – Out
approach in prenatal HIV screening ethically
justified in Sub – Saharan Africa?
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II. Conducting the literature search with specific key
words.
III. Assessing the adequacy of the arguments for and
against this approach
IV. Identifying conclusions drawn in each paper to
assess whether they apply to the identified focused
question.
We searched the following data bases: Pubmed, Cochrane
literature, Embase, Cinhal, Web of Science and Google
Scholar. To carry out a search, the following search terms
were employed: Ethical aspects, HIV screening, Prenatal,
Sub – Saharan Africa, Informed consent, Opt – out, Opt –
in, acceptability and Pregnancy. All articles published in
English and French between 1990 and December 2015 that
were directly related to our research question were carefully
reviewed. Articles which were not related to ethical issues
with regards to HIV screening in pregnancy were excluded.
Reference lists of selected articles were carefully checked
through snowballing to identify other key related articles or
documents of interest.
A total of 302 articles were identified. Article duplicates
were removed. Editorials, policy papers and commentaries
were not included for analysis. After screening, 21 of these
were included for an in depth review. All of the selected
articles were published in English. The main research
question that guided the review and analysis process was:
What are the main ethical arguments in favor of or against
the Provider Initiated Opt – Out Prenatal HIV screening
approach in Sub – Saharan Africa?
Results (The main findings are summarized in
Table 1)
After abstracting the data from selected papers, four
main themes emerged. These were: respect for client
autonomy, beneficence, stigma related issues, coverage
and acceptability of the HIV test.
Autonomy
The principle of respect for autonomy remains the main
recognized and vulgarized principles since the birth of
bioethics. The three main properties of autonomous
decisions include [24]:
I. its intentionality and self – direction
II. adequate understanding of information provided and
III. Absence of coercion.
Health care professionals have the responsibility to
respect, protect and enhance patients’ freedom of choice
[24]. The quantity and quality of the information provided
to the clients if inappropriate can jeopardize the respect of
autonomy with the Opt - Out screening approach espe-
cially amongst pregnant women [12, 16, 25, 26]. The
principle of respect for autonomy remains the main ethical
principle that can easily be breached with the current
provider initiated opt – out screening approach [18, 23, 24].
The theory of libertarian paternalism has been advocated
by some authors, to justify at times a more coercive testing
approach like HIV in pregnancy [12, 13, 18, 27]. They argue
that the incapacity of individuals at times to make decisions
that maximize their own welfare and the protection of the
good of third parties especially in infectious disease
contexts, make some degree of extra compulsion ethically
justifiable [28, 29]. The Opt –Out approach is framed to
encourage person to make the “correct” choice in accepting
the HIV test, while still preserving their freedom to decline
the test [28, 29]. There exists a persistent ethical tension
between the goal of public health to promote the wellbeing
of the mother, the child and society (knowing her HIV sta-
tus, providing appropriate care, prevent HIV transmission
from mother to child, preventing transmission to third par-
ties and partner screening) and the at the same time
respecting the mother’s autonomy [12, 16, 23]. The current
opt – out approach could be considered an ethically
legitimate nudge, that provides a novel paradigm for
informed consent with maintenance of mother’s ability
to turn down the test if she decides to do so [12, 27].
Cohen is convinced that nudging approaches have the
potential to overcome the ethical dilemmas that exist
between paternalistic beneficence and respect for
patient autonomy [29]. This could be considered ideally
ethical if [18]:
I. the clients fully understand the information given
them
II. the information is even given them in the first place
III. they are fully aware of the fact that they have the
right to turn down the test
IV. the decision to accept or turn down the test is void
of all sorts of coercion.
Fulfilling the conditions for a proper counselling could
be very challenging, and most of the times unrealistic.
Improvement in the quality of antenatal care services
offered could permit HIV counselling and screening
under this approach to more or less respect the
autonomy of the clients.
In the Provider Initiated Opt – Out screening approach,
a relatively small amount of time is spent between the
health care provider and the client for counselling [9, 10].
Although this may be considered a drawback, Wanyenze et
al. argue that abbreviated counselling if properly carried out
produces similar, and at times better levels of understand-
ing amongst clients [30]. Although with an inherent oppor-
tunity for the client to turn down the test if she so wishes,
this approach will be ethically justified on grounds that the
client receives the required and complete information
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Table 1 Ethical arguments for or against the Provider Initiated Opt – Out Prenatal HIV Screening
Title Author(s) Year of
Publication
Main Themes
1. Legal and Ethical Implications
of
Opt-Out HIV Testing
Hanssens C [13]. 2007 - Rigid application could trigger legal claims
- Risk of breaching informed consent,
- Disregard or emotional and mental risks
- Could disregard autonomy and dignity
2. Desperately seeking targets:
the ethics of routine HIV testing
in low-income countries.
Rennie and Behets [40]. 2005 - Cannot be effective since clients are generally unaware of the
meaning of the opt –out approach
- Conflict /balance between promoting good (conscious and
unconscious coercion from training of health care staff and insistence
on right to refuse test (wrong message that test is unimportant).
- Reduction of HIV – AIDS related stigma
- Not adapted to areas characterized by high poverty levels, gender
inequalities, weak health care infrastructure and poor access to
treatment
3. HIV testing of pregnant
women: an ethical analysis.
Johansson et al. [12] 2011 - Most effective strategy
- Recognize flip side of the strategy becoming involuntary in the
clinical setting
- Availability and effectiveness of inexpensive drugs makes
intrusiveness of test less important that hypothetical preference of the
child to be born healthy.
4. The Uptake of Integrated
Perinatal Prevention of Mother-
to-Child HIV Transmission
Programs in Low- and Middle-
Income Countries: A Systematic
Review.
Tudor Car et al. [5] 2013 - 11 % of women delivered in labor rooms do not know their HIV
results and did not participate in any HIV prevention programme
- High uptake of the Provider Initiated Opt – Out prenatal screening
approach (96 %)
- Retention in Prevention of Mother to Child Transmission of HIV
Interventions low (17 % of Antenatal care attendees).
5. Routine offer of antenatal HIV
testing (“opt-out” approach)
to prevent mother-to-child
transmission of HIV in urban
Zimbabwe.
Chandisarewa et al. [11] 2007 - More mother/infant pairs receive treatment when screened using
the opt – out approach
- Greater compliance with the opt – out screening approach
- Greater reported satisfaction with this approach compared to the
opt in approach
- Lower reported rates of spousal abuse
6. Consent and antenatal HIV
testing: the limits of choice and
issues of consent in HIV and
AIDS
Sherr at al [14]. 2000 - Poor information transmission from health care providers to
pregnant women with regards to HIV transmission risk and obtaining
consent in antenatal settings could be counterproductive in terms of:
a. Test uptake
b. Optimal goal of minimizing maternal/fetal transmission.
7. Could you have said no? A
mixed-methods investigation of
consent to HIV tests in four African
countries.
Obermeyer et al. [16] 2014 - Underscores HIV testing with current opt – out approach without
any consent from pregnant women (7 %)
- Health care providers actively influence the choices of clients
(21 %)
- Quality of questions asked to evaluate the informed consent
procedure is of utmost importance
- Retrospectively asking clients if they would have said no
overestimates measured levels of coercion
8. Rethinking HIV exceptionalism:
the ethics of opt-out HIV testing
in sub-Saharan Africa.
April [18]. 2010 - Opt – Out testing could increase survival only with effective case
management and sustainability plans
- Opt – out screening encourages test acceptance, while opt – in
screening could increase test refusal rates
- Opt – out screening restricts autonomy, but justifiable on ethical
grounds based on the theory of libertarian paternalism
9. Opt-out HIV testing: an ethical
analysis of women’s reproductive
rights.
Fields and Kaplan [23]. 2011 - Screening approach is at odds with true informed consent
- Reproductive rights principles risk being disregarded if counseling
is not properly done
- Increases testing rates and permits appropriate reproductive
choices to be made by mothers
- Suggests training of health care staff to offer ethically acceptable
counseling and testing, as well as societal actions to decrease HIV
associated stigma and discrimination
10. The sexual ethics of HIV
testing and the rights and
responsibilities of partners.
Dixon-Mueller [54]. 2007 - Rights of individuals to refuse testing ignores the rights of other
sexual partners to be informed of the health risks they are exposed to.
- With the Opt – out testing approach, breaching autonomy could
also go against the right not to know of the clients.
Bain et al. BMC Medical Ethics  (2015) 16:73 Page 4 of 12
Table 1 Ethical arguments for or against the Provider Initiated Opt – Out Prenatal HIV Screening (Continued)
- Opt – out approach justified on grounds of doing no harm to the
fetus
11. Program synergies and social
relations: implications of
integrating HIV testing and
counselling into maternal health
care on care seeking.
An et al. [36] 2015 - Integration of HIV testing with routine care improves confidentiality,
more convenient and less stigmatizing
- Opt – out HIV screening within the prenatal care package is perceived
as compulsory
- Lack of trust in health care staff and non – supportive health care
provider – client relationships aggravates stigma and favors loss to follow
up.
- Social relationships between clients and health care staff must be well
understood and acted upon for this approach to be ethically acceptable
12. Is ‘Opt-Out HIV Testing’ a real
option among pregnant women
in rural districts in Kenya?
Ujiji et al. [15] 2011 - HIV test is considered compulsory by most clients with only 17 %
thinking it is optional.
- High coverage of HIV testing appears to be achieved at the cost of
pregnant women not understanding that testing is optional
13. Routine antenatal HIV testing:
the responses and perceptions
of pregnant women and the




2007 - No pregnant woman tested fulfilled the standard criteria for
informed consent
- Routine testing (Opt – Out) compromises informed consent
- Almost no understanding or false beliefs with regards to a positive
HIV test result amongst most participants
14. An offer you can’t refuse?
Provider-initiated HIV testing in
antenatal clinics in rural Malawi.
Angotti et al. [17] 2011 - An HIV test is a compulsory precondition to receive antenatal care
- Benefits of antenatal HIV testing are more important than choice
- People may increasingly avoid government hospitals for antenatal
services to escape what they perceive to be a mandatory testing
requirement.
15. Rethinking mandatory HIV
testing during pregnancy in areas
with high HIV prevalence rates:
ethical and policy issues.
Schuklenk and
Kleinsmidt [56].
2007 - Prevalence rates of HIV in test refusers generally greater compared
to accepters.
- Argue from a purely consequentialist perspective: stress of
subjecting clients to mandatory test is far less (outweighed) by the
benefits of knowing infected mothers status and implementing
appropriate prevention and treatment strategies
- Provide four preconditions for mandatory screening in high HIV
prevalence settings: woman voluntarily decided to carry fetus to term,
have reasonable alternative courses of action (eg abortions), available
and voluntary HAART treatment and confidentiality should be
guaranteed.
16. The complexity of consent:
women’s experiences testing for
HIV at an antenatal clinic in
Durban, South Africa.
Groves et al. [47] 2010 - Generally, some women have a clear choice to get tested, others
not very sure and others feel they have no choice.
- Direct and indirect coercive techniques employed by heath care
staff to get them tested.
- Further studies to develop mechanisms to simultaneously meet up
with public health goals of widespread test coverage while respecting
women’s autonomy.
17. From caution to urgency: the
evolution of HIV testing and
counselling in Africa.
Baggaley et al. [45] 2012 - Provider Initiated Testing and counseling generally acceptable
throughout Sub – Saharan Africa
- Women generally not aware of the fact that they can decline an
HIV test
18. Practicing provider-initiated HIV
testing in high prevalence settings:
consent concerns and missed
preventive opportunities.
Njeru et al. [48] 2011 - Limited pre and post - test counselling with the provider initiated
opt – out approach.
- Relative neglect on insistence on preventive measures
- Clients frustrated with inability to opt – out
- The opt – out model in prenatal settings deserves to be revisited
and acted upon to maximize protection of client autonomy and
access to effective prevention practices
19. Opt-out HIV testing during
antenatal care: experiences of
pregnant women in rural
Uganda.
Larsson et al. [39] 2012 - Clients consider test as compulsory
- Benefits of getting an HIV status result not fully discussed to clients
and not understood by clients
- Compulsory testing could deter clients from seeking antenatal care
- Gender sensitive models need to be recognized to encourage
partner screening
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package [9, 10, 27], that the health care provider has the
required expertize in communicating appropriately gener-
ally within a limited amount of time and that the health
provider herself has the required knowledge. With these
preconditions generally unmet in most health care set-
tings, the question of how informed the informed
consent is under this approach remains troublesome.
Obermeyer et al. in a study in four African countries
(Burkina Faso, Kenya, Malawi and Uganda) reported
that 7 % of clients were tested without any consent.
With this provider initiated opt out HIV screening
strategy, many clients from most recent studies in
Sub – Saharan Africa have reported that they were
not aware they could have an opportunity to decline
the test if they wanted to and that they were coerced
to undertake the test as a precondition to continue
receiving health care in their respective health facilities
[16, 25, 26, 31, 32].
Another argument in favour of the Provider Initiated
Opt – Out approach has been that the extensive pre-test
counselling and written consent that were inherent to the
opt – in approach and voluntary testing and counselling
deterred clients from being tested [33]. Hanssens has
highlighted that this approach might not appropriately
take into consideration consequences like labelling,
psychological distress and post-test discrimination by
health care providers with patients that turn out to be
HIV positive [13].
Beneficence
Most authors argue that knowing one’s HIV status
permits a timely initiation of appropriate therapies,
generally affordable and effective today to decrease HIV
associated morbidity and mortality [2, 4]. Provision of
treatment today is amongst the most important benefits
if getting an HIV test done [2, 18]. This is especially
important for pregnant women as this could help them
in making informed reproductive choices [23]. Liddicoat
et al. found in a retrospective analysis of the charts of
221 HIV positive patients who had encountered a health
care provider in the previous year, that the risk and need
to carry out an HIV test amongst these clients were not
properly addressed and the HIV test was only proposed
to 27 % of these persons [34]. This suggests that when
the responsibility is left in the hands of health care
providers to recommend an HIV test on a case by case
basis, more missed HIV test opportunities can be
recorded [23]. Knowing one’s status ideally enables
early initiation of treatment, which reduces the spread
of the infection [2]. Massive detection might require
health systems to be prepared to treat all HIV infected
mothers. However, it might be difficult to ascertain if
health systems in Sub – Saharan Africa could accom-
modate and appropriately manage larger numbers of
pregnant women infected with HIV. April [18], Wocial
and Cox [27] have proposed that the sustainability and
guaranteeing of proper medical care to all women who
shall test positive as recommended by the WHO [9]
need to be properly evaluated before vulgarizing the
Opt – Out screening practice in high HIV prevalence
settings like Sub – Saharan Africa. If not, the negative
social and psychological consequences that could arise
might instead outweigh the benefits from knowing
their HIV status (e.g. stigma, social exclusion).
Stigma
The Provider Initiated Opt –Out prenatal screening
approach has been embraced as a less stigmatizing
approach, compared to the usual voluntary testing and
counseling or opt – in approaches [9, 23, 33, 35]. The
reason given for this is that, as part of routine medical
care, HIV becomes treated like all other “normal” or
usual diseases [9, 10]. However, some authors fear that
vulgarizing prenatal HIV screening as with the Opt –
Out approach if not well considered could worsen
HIV associated stigma [18, 27, 35, 36]. Inadequate and
Table 1 Ethical arguments for or against the Provider Initiated Opt – Out Prenatal HIV Screening (Continued)
20. HIV/AIDS Stigma and Refusal
of HIV Testing Among Pregnant
Women in Rural Kenya:
Turan et al. [61] 2011 - Women who recognize getting stigmatized if partners know their
results are more likely to refuse an HIV test, or be compliant to
treatment
- Anticipated stigma could be barriers to accepting HIV screening by
pregnant women
- The Opt – Out approach if compulsory without taking into account
this reality could aggravate stigma and thus become
counterproductive.
21. An Ethical Analysis of
Opt-Out HIV Screening for
Pregnant Women
Wocial and Cox [27]. 2007 - Opt – out approach justified on the basis of the potential good to
the general public (beneficence).
- Respects autonomy since it is not a discriminatory process
- Everyone is screened without discrimination nor neglect of
marginalized individuals (justice).
- Effective counseling empowers women to take more rational
decisions and reduce transmission to their infants
- Opt – Out approach considered to be ethically defensible,
especially if counseling of women is effectively acted upon.
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inappropriate counseling, disregard of sociocultural peculi-
arities and lack of sustainability of the medical care package
before and after the test have been identified as key action
areas deserving amelioration. In Sub – Saharan Africa
where gender bias and HIV associated stigma are still
serious concerns, expanded HIV testing risks resulting in
other consequences like discrimination, domestic violence
and abandonment [37–39]. Csete et al. have proposed
incorporation of measures to fight against gender violence
and abuse within the package of the Opt – Out screening
approach [37]. These include: emergency helplines,
training of police and social service staff on issues of
AIDS related violence against women, criminalization of
marital rape and school based awareness programmes
for girls and boys. Rennie and Behets have argued that
in settings characterized by extreme poverty, weak
health care and civil society capacities, gender inequality
and high levels of stigma against HIV – AIDS patients,
the Opt – Out HIV screening approach might divert
from its initial human rights motivations of offering
universal access to HIV – AIDS management [40]. They
recommend continuous empirical research to assess the
effects of this approach on individuals and communities,
from both ethical and human rights perspective, especially
when implemented in resource limited settings.
Coverage and acceptability
The Provider Initiated Opt – Out Prenatal HIV Screening
approach has been reported to be associated with an
increase in the uptake of the HIV test [9, 41–44]. Research
from most studies in Sub Saharan Africa have described
this approach is being generally more acceptable to clients
compared to the former Opt - In approach. The accept-
ability rates range from 80 % to 97 % in most prenatal care
clinics [11, 12, 41–45]. With the voluntary counselling
and testing approach (Opt – In), acceptability rates have
generally been low rarely going over 80 % [2, 9]. True and
informed acceptability of the opt - out approach has
however been put to question [14, 15, 17, 25]. Empirical
research findings have been increasingly revealing that the
HIV test options presented to pregnant women are biased:
no true voluntary options to accept or turn down the test,
most clients directly or indirectly coerced to take the test
and the quality of the informed consent process described
generally as poor [17, 25, 46], 41]. Most clients have
reported that the test was presented to them as compulsory
by health care providers and many did not know they
had an option to turn down the test if they wanted to
[39, 46–49]. Johansson et al. also highlight the risk of
the Opt - Out approach becoming an involuntary
testing strategy if implemented in a real setting without
caution [12]. Larsson et al. have recommended active
monitoring and evaluation as key components of the
Opt – Out prenatal HIV screening practice [39].
Discussion
The aim of this review of the argument – based literature
was to identify ethical arguments pro and against the
Provider Initiated Opt – Out Prenatal HIV screening
approach in Sub – Saharan Africa. The World Health
Organization (WHO) has specified the minimum package
of information to be given to clients during the informed
consent process including the tests clinical and prevention
benefits, the right to refuse the test, the follow – up services
that will be offered and the need to anticipate informing
any contacts at risk in case the test turns out positive [9].
These conditions are rarely met in most health care
settings. Even in developed countries, many women are still
seen in labor rooms with unknown HIV serostatus. For
instance, Siemieniuk et al. reported cases from Alberta in
Canada who were diagnosed either in the labour room or
postpartum [20]. About 32 % of women who give birth
in Sub – Saharan Africa do so without ever receiving
any prenatal care [4, 8]. The Opt out prenatal screening
approach should therefore be coupled with increased
efforts to improve prenatal care coverage, which has
improved, but remains below expectations in this region of
the world. The risk of rendering health care professionals
negligent and not able to provide the necessary information
as required is a major risk of this approach, especially in a
region of the world with very limited human resources in
health care. Wanyenze et al. have however proposed that
abbreviated counselling models with the Opt – Out
approach, if well formulated and implemented could
produce similar, and even better results compared to the
voluntary time consuming standard HIV counselling and
testing approaches [30]. This could be worth experimenting
in a Sub – Saharan African context, as this region is ser-
iously challenged with scarcity in health care professionals.
Informed consent, for whom?
For the health care staff or for the patient’s? Informed
consent remains a crucial requirement in both healthcare
and research settings. However, many scholars have stated
that fulfilling its requirements is unrealistic and even
mythical [50, 51]. Even in developed countries with gener-
ally higher levels of education and more information, most
of the patients never fully understand the informed
consent form that they do sign [36, 52]. Without written
consent, the likelihood that the test becomes compulsory
increases [12, 53]. However, Bayer has argued that making
it more difficult to say no with regards to taking an HIV
test within the opt – out approach can be justified from a
public health perspective. He is particularly concerned
with the opportunities accrued to treating the infected on
time, avoiding treatable and preventable opportunistic
infections and reducing transmission to their partners
[53]. Dixon-Mueller supports making it more difficult for
persons to say no to getting tested from a rights based
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approach [54]. She argues that labelling the provider initi-
ated opt – out approach as disempowering since some cli-
ents may not feel free to say no undermines these same
people’s rights to know their HIV status and to make sex-
ual and reproductive decisions based on this information.
In settings where the levels of education and awareness
with regards to human rights are generally lower, this be-
comes a serious ethical concern to be tackled more care-
fully. With this screening approach, clients have been
reported to be totally unaware that they were tested for
HIV or been directly or indirectly coerced to get tested
[16, 17]. Being unaware of an existing option to turn down
the test could reduce the provider initiated opt – out HIV
screening approach to compulsory HIV screening [23, 27].
In the United Kingdom, Sheer et al. reported over 18 %
of the tested pregnant women for HIV believing they
could not refuse the test [14]. Njeru et al. have reported
limited pre and posttest counseling in Kenya, Tanzania
and Zambia as well as neglect of preventive measures with
the Provider Initiated Opt – Out HIV screening approach
[48]. Considering that these are high HIV prevalence
settings, the intended benefits of expanded screening
could be blurred by consequences that could result from
coercion, test without consent, aggravated stigma, distrust
in healthcare staff and non – compliance to recommended
treatment regimens even amongst those tested positive
[14, 16, 18, 19, 39, 55]. Fields and Kaplan have argued that
protecting the best interest of the fetus and enhancing the
general good for society (beneficence) through excessive
“paternalistic” HIV screening of pregnant woman is
ethically unacceptable [23]. They propose a health care
model with health care staff being committed to
provide the best available care as well as respecting as
much as possible the autonomy of the patients. On the
other hand, Johansson et al. think that despite the fact
that the Opt –Out strategy might become involuntary
in the clinical setting, it remains acceptable [12]. They
base their arguments on the fact that the increased
availability of very effective and inexpensive lifesaving
drugs renders ethical concerns raised by an intrusive
HIV testing practice less important compared to the
child’s hypothetical preferences to be born healthy
[12]. Effective drugs for the management of HIV are
generally effective, available and affordable in most
Sub – Saharan African countries today [2, 4]. Schuk-
lenk and Kleinsmidt are comfortable with the Opt –
Out screening approach even if it could turn out to be
compulsory HIV screening especially in areas with
high prevalence rates like in Sub – Saharan Africa
[56]. They however provide key preconditions for this
compulsory testing to be ethically justified. These are:
I. the women in question would have had voluntarily
chosen to carry the fetus to term
II. they would have had a reasonable alternative to this
course of action (e.g., abortion at least until the
point of fetal viability)
III. continuing voluntary treatment with HAART
would be available to them
IV. The confidentiality of the women’s HIV status
should ideally be maintained during as well as after
their pregnancy (not imperative).
The ethical framework driving their reasoning however
was purely consequentialist in nature [56]. They fail to take
into account possible serious psychological consequences
(stigma and social exclusion) and confidentiality issues
could arise if the HIV test becomes practically compulsory
in prenatal care settings [18, 27, 37]. The Provider Initiated
Opt – Out Prenatal HIV Screening approach runs these
risks if it is not implemented with caution.
Empirical research in bioethics has been embraced and
its importance has generally been well recognized [57, 58].
Despite concerns raised by empirical research about the
disregard or inappropriate practice of the informed consent
procedure, coercion or compulsory testing with this testing
approach,[15–17, 25, 26, 31], it might be of interest for
public health actors to embrace these claims with caution
[16, 57, 58]. As Obermeyer et al. have reported in a study
from four African countries that based on the type of
question asked, coercion can be overestimated especially
when the women are questioned retrospectively [16]. With
the closed question “could you have said no”, which has
generally been used in most empirical research endeavors
to evaluate the quality of informed consent, coercion was
overestimated at 77 %. In depth analysis however revealed
that 60 % of these women actually consented to get tested.
In the quest for efficiency or adequacy?
Efficiency must be clearly differentiated from adequacy.
Considerations regarding the former most of the time
compels health care staff to offer the HIV test simply as
part of their job, or to take specific precautions not to
get infected when caring for the pregnant women during
delivery. Under such circumstances, the responsibility of
health care staff as moral agents is eroded [27]. From an
ethical perspective, the concept of adequacy possesses
an internal morality and should normally generate a
moral impulse that the patient receives during the
informed consent process. Sherr et al. have underscored
the importance of the quality of information given to
pregnant women in antenatal clinics and that of a
proper process of obtaining informed consent [14]. If
not appropriately acted upon, they highlight how counter-
productive this could turn out by reducing the HIV test
uptake rates and consequently decreasing the chances for
preventing the transmission of HIV from the mother to the
child. Eyal has argued this constitutes the bases of trust
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which is key for compliance to proposed behavioral and
biomedical regimes in case the mother is infected [19]. He
also argues that Coercion, deception, manipulation and
other violations of standard informed consent requirements
seriously jeopardize the trust, which remains a key require-
ment for people to seek medical advice, comply with it, and
participate in medical research. The success of the Highly
Active Anti-Retroviral Therapy used today in managing
patients with HIV – AIDS is almost dependent on compli-
ance [2]. Non – compliance does not only lead to poor
outcomes in persons infected, but could also predispose to
the development and spread of drug resistant strains of the
virus. This is already a growing challenge for public health
actors in this region of the world [2, 59, 60]. It is rare and
most of the time almost inexistent to find skilled staff
(Clinical/psychologists, counselors and social workers)
being implicated in the diagnosis and care process of
mothers infected with HIV. Despite the reported
decrease in levels of stigma associated with HIV – AIDS,
the condition still remains a very stigmatization condition
and it shall take time for this to reduce to expected and
enviable levels [1, 2, 9]. Adequate HIV counseling and
screening could guarantee a better understanding of the
prevention and treatment options, their effectiveness,
available alternatives, dispel false beliefs (reduce stigma)
and strengthen trust between the health care staff and
society [19]. Challenging the knowledge and beliefs of
clients with regards to HIV is a sign of respect for her and
renders her decisions to be truly well informed (strength-
ening her autonomy) [24].
Chandisarewa et al. have reported more infant/mother
pairs receiving antiretroviral prophylaxis and follow up
in clinics with the opt – out approach compared to the
opt – in screening approach (p <0.01) [11]. Tudor Car et
al. have reported in a recent systematic review a high up-
take (96 %) of the current opt – out HIV screening
approach in prenatal care services [5]. They also paradox-
ically report a less than expected (17 %) retention rate on
current HIV prevention programs of the infected mothers
and children at risk. This could be indicative of the fact
the testing is not done under optimal conditions to ensure
compliance to the available HIV management protocols in
this population. There is some skepticism of an inappro-
priate application of this approach which can instead
deter clients from seeking care and lead to loss to follow
up [19, 55]. Becker and collaborators have argued that
uncoordinated and non-comprehensive aggressive testing
could lead to stigmatization and could deter patients from
meeting health care providers for the management, not
only of HIV, but other diseases [55]. De Zulueta and
Boulton have also reported how health care staff
indirectly coerce clients to accept HIV testing. In their
study, only two out of thirty-two (32) women were
aware of the possibility of a woman, HIV positive,
giving birth to an uninfected child [46]. This could
depict some degree of lack of information and inad-
equate counseling skills on the part of the health care
staff, or purposeful selective retention of certain pieces
of information to coerce the pregnant women to
accept the test [46].
HIV with the growing availability and affordability of
the treatment for sure has become a chronic condition
with most persons leading a normal quality of life as
the uninfected [2]. However, we argue that the most
important purpose of getting an HIV test is not getting
to know one’s status. The behavior after obtaining the test
results remains capital for prevention and care purpose. An
HIV test done under inappropriate conditions could be a
guarantee for clients to flee from coming for follow up after
results, many not even turning up for the test results and
non – compliance [19, 26]. Sub Saharan Africa is facing a
growing epidemic of non – compliance to HAART in most
areas and associated HIV resistance [59, 60]. April suggests
that the potential gains of this approach if appropriate
measures to fight against loss to follow up of patient tested
positive are not taken will be negligible [18]. He thinks that
the lack of mechanisms to track, educate and monitor
diagnosed patients risk eroding the expected gains from
the Opt – Out HIV screening approach. As the world and
scientific community enviably awaits a vaccine or complete
cure medications for HIV, securing the effectiveness of
available medications through avoidance of non-adherence
to treatment and drug resistance remains critical. The
quality of the counseling, consent and screening process
could be useful avenues to enhance healthy health care
provider – client relationships, foster trust and conse-
quently posttest compliance to recommended treatment
(prevention) options [19, 40, 55].
The Provider Initiated Opt – Out Prenatal HIV
Screening approach might not necessarily clash with
client autonomy if appropriately implemented. From a
public health perspective, good quality counseling (void
of direct or indirect coercion) using an appropriate,
pretested and validated abbreviated model could still
allow pregnant women to voluntarily decide on whether
to take the test or not. More women will come to know
their status, receive early treatment and appropriate
interventions to reduce the transmission of HIV from
mother to child. It is unclear if the Opt – In approach
actually enhances the autonomy of the tested parties,
since clients at times still feel pressured to undertake
the test [9, 18, 27]. Anticipated stigma and discrimin-
ation if one turn’s down the test could deter clients
from taking the test [61]. An atmosphere of trust and
confidence remains a key determinant of test uptake
and compliance to evidence based recommendations
given to these patients by health care providers. Third
party interests in infectious disease scenarios might
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compel some degree of compulsion to protect third
parties. With HIV in pregnancy, it might be argued that
some degree of soft compulsion (soft paternalism) is
ethically justified to protect the interest of the baby
who has a high potential of being born HIV free today.
Conclusion
The Opt – Out HIV screening approach in prenatal settings
has been generally justified on the grounds of beneficence,
reduced HIV associated stigma and increased uptake.
Irrespective of the fact that the benefits that could arise
from knowing the HIV status of pregnant women with this
approach could outweigh potential psychological and social
harm of knowing one’s HIV status, this does not in any way
relief healthcare providers of their responsibility to properly
educate and counsel women [27]. The breaching of respect
for autonomy has been considered generally acceptable
based on the concept of libertarian paternalism, with
reference made to its overwhelming potential benefits to
the individual himself, the unborn child and the society.
The quality of counseling and the informed consent process
has generally been reported as being poor or at times
nonexistent. It is difficult therefore to directly associate the
reported high acceptability rates of the test to voluntariness.
Despite the increase in the number of patients that are
being screened with the current provider initiated opt out
HIV screening strategy, the conditions under which the
screening is done remains key and deserves proper research
and action from policy makers. It is unclear whether health
systems can effectively manage the growing number of
patients tested positive with this expanded screening
approach as recommended by the WHO guidelines. If not,
is it ethically justifiable to get persons come to know they
are HIV positive despite the unavailability of an acceptable
posttest management package? The potential gains of
knowing one’s HIV status are plausible from the prevention
and treatment arms, but need to be carefully balanced with
the often ignored psychological and social consequences of
letting known HIV positive clients go without treatment.
Knowing one’s status already is an initial step to intervene
to reduce passing the infection from mother to child, and
also spreading the virus to third parties. Improving the
quality of counseling and psychosocial support staff within
the clinical setting in Sub Saharan Africa remains critical.
Adequate training of staff specialized in dealing with
psychological components of HIV and increase in
training of counselors in this domain could be a good
beginning. Adequacy of the screening and not mere
attaining of targets could be of interest to public
health. If not appropriately worked upon, stigma and non-
compliance to prevention and treatment protocols might
persist. This could result in more infections than expected,
high mortality rates, continuous disease transmission “in
the shadows” when persons shy away from getting tested
and resistance to the current effective biomedical regimes.
Efforts to maintain the moral intention of informed
consent to protecting the interest of the patient must be
reemphasized. If not adequately acted upon, not only shall
non – compliance to biomedical treatment regimens for
HIV increase with accompanying increase in HIV resistant
strains, public health risks experiencing a loss in public
trust in health systems and an accompanying decrease in
the willingness to use HIV prevention/treatment services
and participate in future research. This might not be of
any good to the health care systems especially when the
“abused clients” come to better understand their rights in
the near future.
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